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Multifaceted changes in Synaptic 
composition and Astrocytic 
involvement in a Mouse Model of 
fragile X Syndrome
Anish K. Simhal  1, Yi Zuo  2, Marc M. perez3, Daniel V. Madison3, Guillermo Sapiro1,4 & 
Kristina D. Micheva3
fragile X Syndrome (fXS), a common inheritable form of intellectual disability, is known to alter 
neocortical circuits. However, its impact on the diverse synapse types comprising these circuits, or on 
the involvement of astrocytes, is not well known. We used immunofluorescent array tomography to 
quantify different synaptic populations and their association with astrocytes in layers 1 through 4 of the 
adult somatosensory cortex of a FXS mouse model, the FMR1 knockout mouse. The collected multi-
channel data contained approximately 1.6 million synapses which were analyzed using a probabilistic 
synapse detector. Our study reveals complex, synapse-type and layer specific changes in the neocortical 
circuitry of FMR1 knockout mice. We report an increase of small glutamatergic VGluT1 synapses in layer 
4 accompanied by a decrease in large VGluT1 synapses in layers 1 and 4. VGluT2 synapses show a rather 
consistent decrease in density in layers 1 and 2/3. In all layers, we observe the loss of large inhibitory 
synapses. Lastly, astrocytic association of excitatory synapses decreases. the ability to dissect the 
circuit deficits by synapse type and astrocytic involvement will be crucial for understanding how these 
changes affect circuit function, and ultimately defining targets for therapeutic intervention.
Fragile X Syndrome (FXS) is the most common inheritable form of intellectual disability, affecting approximately 
1 in 7,000 males and 1 in 11,000 females across all races and ethnic groups1. FXS patients display a wide spectrum 
of phenotypes, including moderate to severe intellectual disability, autistic behavior, macroorchidism, predispo-
sition to epileptic seizures, and facial abnormalities2–4. FXS is caused by the silencing of the FMR1 gene, which 
encodes the Fragile X Mental Retardation Protein (FMRP). FMRP is known to play an important role in trans-
lation, trafficking, and targeting of a large number of mRNAs in neurons5–7. FMRP also binds to many proteins, 
suggesting its involvement in a wide variety of functions, such as genome stability regulation, cell differentiation, 
and ion channel gating8. Because FMRP participates in a multitude of processes in cells, it has proven difficult to 
understand how FMRP deficiency affects the synapses and neuronal circuits in brain to cause the FXS pathology.
The mouse model of this disease, the FMR1 knockout mice, display similar phenotypes to human FXS, such 
as deficiency in learning and memory9–11, sensory processing12,13, and social behaviors14,15. However, despite these 
profound neurological and behavioral deficits, the reported changes at synapses have been rather subtle, with 
basic synaptic neurotransmission seemingly unaffected. At the synaptic functional level, FMR1 KO mice display 
region-specific deficits in plasticity, such as abnormal long-term potentiation (LTP) and long-term depression 
(LTD)8. Many of the molecular signaling pathways at synapses appear dysregulated, but the changes are often 
region and neuron-type specific, and the contributions of specific signaling pathways to the Fragile X pathology 
have been difficult to untangle16. At the synaptic structural level, the most obvious difference is the higher density 
of immature, long and thin dendritic spines of pyramidal neurons in the cortex of adult FMR1 KO mice compared 
to WT controls11–15.
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The unusually long and thin spines which are also found in fixed tissues of FXS patients9,10,17,18, are similar to 
the immature spines observed during development19–21. This observation has led to a popular hypothesis that the 
absence of FMRP in the nervous system causes a defect in spine maturation and pruning, which in turn alters 
synaptic connectivity and ultimately results in behavioral defects6,7,22–24. While dendritic spine morphology and 
structural dynamics are good indicators of modifications in synaptic connectivity25–27, they cannot fully represent 
the diversity of cortical synapses. For example, the majority of inhibitory synapses terminate on dendritic shafts 
and somata, and are thus not accounted for by changes at spines. Among the excitatory synapses terminating on 
spines there are cortico-cortical synapses containing the vesicular glutamate transporter VGluT1 and thalamo-
cortical synapses containing VGluT228,29, which have very different functions in the cortical circuitry. The impact 
of FXS is likely to be dependent on synapse type because of the differential expression of FMRP across neuronal 
types30. Indeed, a recent study using highly multiplexed array tomography showed the varied impact of FXS on 
synaptic populations of cortical layer 4 and 5 in FMR1 KO mice31.
To add a further layer of complexity, FXS may also affect certain non-neuronal cells. As the most abundant 
glial cells in the mammalian brain, astrocytes modulate synaptic structure and function32 and are implicated in 
many neurodevelopmental diseases33. In the mouse brain, astrocytes also express FMRP34, and FMR1 KO mice 
have fewer hippocampal synapses associated with astrocytes35. Interestingly, astrocyte-specific deletion of FMR1 
leads to significantly more immature spines in the mouse motor cortex due to overproduction of spines during 
development36. Whether such astrocytic contribution varies according to synapse type is not yet known.
To better understand the synapse type-specific effects of FXS on the neocortical synaptic circuitry, we investi-
gated the changes in different synaptic populations and their association with astrocytes in the adult mouse soma-
tosensory cortex, an area in which a variety of deficits have been reported for FMR1 KO mice37–39. We focused on 
the superficial cortical layers where live-imaging studies have revealed changes in dendritic spine formation and 
turnover37,40, but the synapse type specificity of the FXS effects is unknown. In order to investigate large numbers 
of synapses of different types, we used immunofluorescent array tomography (IF-AT) which allows for the light 
level detection of individual synapses within brain tissue, and the ability to apply multiple markers to distinguish 
synapse types41,42. Synaptic density was quantified using automatic synapse detection methods previously devel-
oped by our group43,44. Our results reveal multifaceted changes in the composition and astrocytic involvement in 
the synaptic circuitry of the somatosensory cortex of adult FMR1 KO mice.
Methods
overview. The methods section is divided into two main components — data generation and computa-
tional analysis. The data generation section specifies the types of mice used, the antibodies used, and the imag-
ing methodology. The computational analysis section highlights the methods used to automatically analyze the 
array tomography data, including the detection of synapses by their specific type and the detection of astrocytes. 
Processing and imaging each mouse took ten days on average, resulting in approximately 40GB of image data. 
The analysis scripts, running in parallel, took eleven days on a twelve core computer and generated approximately 
800GB of auxiliary data.
Data generation. The datasets investigated were obtained from the somatosensory cortex of adult mice and 
represent layers one through four. The somatosensory cortex was chosen because of the well-documented deficits 
in FMR1 KO mice in this cortical region37–39. We focused on the superficial cortical layers for which more infor-
mation is available through live imaging studies37,40. The average dataset volume was 135,588 μm3.
Animals. Mice were group-housed in the University of California, Santa Cruz (UCSC) animal facility, with 
12 hour light-dark cycles and access to food and water ad libitum. All procedures were performed in accord-
ance with protocols approved by the Animal Care and Use Committee (IACUC) of UCSC. FMR1 KO mice were 
obtained from Dr. Stephen T. Warren, Emory University. Thy1-YFP-H mice were purchased from JAX. All mice 
were backcrossed with C57BL/6 mice more than 10 generations to produce congenic strains. For the current 
experiments, YFP+ WT males were crossed with YFP- FMR1+/− females, and only male offspring litter-mates 
were used for the experiments. WT mice refer to FMR1+/y, and KO mice are FMR1−/y. Because the YFP expres-
sion was highly variable between animals, we did not use it in the analysis. Four KO mice and three WT mice 
were used for the analysis. The mice were four months old when they were sacrificed. Further details about the 
mice are in Supplemental Table S1.
Array tomography. The tissue was prepared using standard array tomography protocols42. The mice were 
anesthetized by halothane inhalation and their brains quickly removed, cut into 2 mm slices, fixed by immersion 
in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 1 hour at room temperature, then left in the fixa-
tive overnight at 4 oC. After rinsing in PBS, the somatosensory cortex was dissected out, quenched in 50 mM gly-
cine in PBS for 30 minutes and dehydrated in a series of ethanol washes (50%, 70%, 70%) at 4 oC, then infiltrated 
and embedded in LRWhite resin in gelatin capsules, and polymerized at 50 oC for 24 hours.
To prepare ribbons of serial sections, the blocks were trimmed around the tissue to the shape of a trapezoid, 
and glue (Weldwood Contact Cement diluted with xylene) was applied with a thin paint brush to the leading and 
trailing edges of the block pyramid. The embedded plastic block was cut on an ultramicrotome (Leica Ultracut 
EM UC6) into 70 nm-thick serial sections, which were mounted on gelatin-coated coverslips.
immunolabeling. Sections were processed for standard indirect immunofluorescence, as described in42. 
Antibodies were obtained from commercial sources and are listed in Table 1. Array tomography specific controls 
are presented in Supplemental Table S2. The sections were incubated in 50 mM glycine in TBS for 5 minutes, fol-
lowed by blocking solution (0.05% Tween-20 and 0.1% BSA in TBS) for 5 minutes. The primary antibodies were 
diluted in blocking solution as specified in Table 1, and were applied for 2 hours at room temperature or overnight 
3Scientific RepoRtS |         (2019) 9:13855  | https://doi.org/10.1038/s41598-019-50240-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
at 4 oC. After a 15 minutes wash in TBS, the sections were incubated with Alexa dye-conjugated secondary anti-
bodies, highly cross-adsorbed (Life Technologies), diluted 1:150 in blocking solution for 30 minutes at room 
temperature. Finally, sections were washed with TBS for 15 minutes, rinsed with distilled water and mounted on 
glass slides using SlowFade Gold Antifade Mountant with DAPI (Invitrogen). After the sections were imaged, the 
antibodies were eluted using a solution of 0.2 M NaOH and 0.02% SDS for 20 minutes, and new antibodies were 
reapplied. Several rounds of elution and re-staining were applied to create a high-dimensional immunofluores-
cent image. Samples were immunostained side by side in pairs, consisting of one WT and one KO sample, and 
imaged immediately after completion of staining.
imaging method. The immunostained ribbons of sections were imaged on an automated epifluorescence 
microscope (Zeiss AxioImager Z1) using a 63x Plan-Apochromat 1.4 NA oil objective. For each section from 
the ribbon, an area of 140 μm × 400 μm was imaged and this area encompassed layers 1 through 4. The entire 
imaged volume was analyzed, but it was subdivided into separate subvolumes corresponding to the different 
layers. To define the position list for the automated imaging, a custom Python-based graphical user interface, 
MosaicPlanner (obtained from https://code.google.com/archive/p/smithlabsoftware/), was used to automatically 
find corresponding locations across the serial sections. Images from different imaging sessions were registered 
using a DAPI stain present in the mounting medium. The images from the serial sections were also aligned using 
the DAPI signal. Both image registration and alignment were performed with the MultiStackReg plugin in FIJI45.
computational analysis. A main goal of this analysis is to examine the effects of the lack of FMRP protein 
on the synaptic composition of the somatosensory cortex. This requires the ability to quantify synapses by their 
molecular composition and their adjacency to an astrocytic process. To achieve this, we took existing methods 
and expanded their scope to meet the computational challenges posed by these experiments, including develop-
ing a method for detecting astrocyte processes adjacent to synapses. The computational analysis was conducted 
blindly. The samples were imaged in pairs of one WT and one KO mouse by MMP and the de-identified image 
files were sent to AKS for analysis.
Synapse detection. For the present purposes, we define ‘synapse type’ as a specific combination of synaptic 
proteins. For example, a GABAergic (inhibitory) synapse type is defined by the presence of the general presyn-
aptic marker, synapsin; the postsynaptic marker of inhibitory synapses, gephyrin; and the presynaptic marker of 
inhibitory synapses, GAD. A glutamatergic (excitatory) synapse is defined by the presence of the general presyn-
aptic marker, synapsin, and the postsynaptic marker for excitatory synapses, PSD-95. A glutamatergic synapse 
with VGluT2 and adjacent to an astrocytic process is defined by the presence of synapsin, VGluT2, PSD-95, and 
GS, a marker for astrocytes.
Detecting synapses by their molecular composition is the first step of the computational pipeline. In order to 
quantitatively analyze large array tomography volumes, it is vital to find an appropriate synapse detection tech-
nique. The majority of published synapse detection methods use traditional machine learning approaches43,46–48. 
These approaches all consist of a few common steps to detect synapses. First, for each synapse type, a large num-
ber of synapses are manually identified and labeled in the array tomography data. Next, a classifier (such as a 
support vector machine or convolutional neural network) is trained with these manual annotations. Lastly, the 
entire dataset is appropriately parcellated and potential synapses are labeled by the classifier. While this method 
works well for certain questions in synapse biology, the difficulty in manually labeling different synapse types in 
immunofluorescent data renders it ineffective for our applications.
The probabilistic synapse detection method introduced in43, is a synapse type focused approach which does 
not require any training data, making it a viable option for exploring synapses imaged via array tomography. 
‘Synapse type’ focused means the user specifies the molecular composition and the relative spatial arrangement 
along with the size of the synaptic markers prior to running the probabilistic synapse detection method. The com-
bination of a user-defined synapse type and marker size is called a ‘query’, as highlighted in Fig. 1.
A query to detect a glutamatergic synapse would look like the following: a PSD-95 punctum of a minimum of 
2 px × 2 ps × 2slices (which is 0.2 μm × 0.2 μm × 0.14 μm for our data) adjacent to a synapsin punctum of the same 
size. Adjacency in this case means that the puncta of the two different antibody markers do not occupy the same 
space but instead are juxtaposed with each other, i.e., occupy immediately adjacent pixels or share a small propor-
tion of pixels. Since PSD-95 is a postsynaptic protein and synapsin is presynaptic protein, this simple glutamater-
gic synapse query follows the known biological model for glutamatergic synapses. In43, the query comprises only 
Antigen Host Antibody Source RRID Dilution
Synapsin Rabbit Cell Signaling 5297 RRID:AB_2616578 1:100
PSD95 Rabbit Cell Signaling 3450 RRID:AB_2292883 1:100
VGluT1 Guinea pig Millipore AB5905 RRID:AB_2301751 1:5000
VGluT2 Guinea pig Millipore AB2251 RRID:AB_2665454 1:5000
GAD2 Rabbit Cell Signaling 5843 RRID:AB_10835855 1:100
Gephyrin Mouse NeuroMab 75-443 RRID:AB_2636851 1:100
Glutamine synthetase Mouse BD Biosciences 610517 RRID:AB_397879 1:25
Table 1. Antibodies used for the experiments.
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of presynaptic and postsynaptic makers. In this work, we have expanded the query to comprise of presynaptic, 
postsynaptic, and astrocytic markers. This combination of markers is often referred to as a ‘tripartite synapse’46. 
As the left side of Fig. 1 shows, the tripartite synapse model assumes that the molecular markers for each ‘subclass’ 
(presynaptic, postsynaptic, astrocytic) lie adjacent relative to each other.
In summary, the probabilistic synapse detector is a method of detecting specific synapse types. Instead of 
requiring the user to manually annotate multiple instances of a synapse type to train a machine learning classifier, 
the query-based approach asks the user to define a synapse by specifying basic characteristics, that is, the requisite 
markers, requisite punctum volume for each marker (which depends on the microscope known resolution), and 
their relative spatial arrangement.
Once the query has been established, the probabilistic synapse detection method follows the query to auto-
matically detect synapses matching the query. Figure 2 shows an example pipeline going from the raw input 
data to the thresholded synapse detections. Briefly, synapses are detected in IF-AT data through a series of steps. 
First, the user defines what the detection should look like. For example, it should consist of a synapsin punctum 
and PSD-95 punctum that lie adjacent to each other and each punctum should be at least two pixels by two 
Figure 1. Outline of a query. The cartoon on the left side shows the relative spatial arrangement of the different 
fluorescent markers used to detect an excitatory synapse expressing VGluT1, next to an astrocyte process. This 
visual description of a synapse is translated into a query, shown to the right of the large black arrow. A query is 
a user-defined description of what the synapse type of interest should ‘look’ like. In this case, the presynaptic 
protein markers - synapsin and VGluT1, are expected to colocalize (occupy the same 3D space) with each 
other. Furthermore, the presynaptic, postsynaptic, and astrocyte markers (as a group) are all expected to be 
next to each other. The top right portion of the figure shows three 1.5 μm × 1.5 μm cutouts of different marker 
combinations showing what the query looks like in the data. The first cutout shows the synapsin and PSD-
95 punctum overlaid; the second cutout includes the GS punctum and the third cutout includes the VGluT1 
punctum.
Figure 2. Probabilistic synapse detection pipeline. The first column shows the raw PSD-95 and synapsin data. The 
second column shows the output of the synapse detection method, where the value at each pixel is the probability 
that pixel belongs to the specified definition of a synapse. The third column shows the results of thresholding the 
output probability map. From our past work, we determined an empirical threshold of 0.9 to be the optimal value. 
The forth column shows the detections (in white) overlaid upon the superposition of the PSD-95 and synapse 
data. For this visualization, the definition of a synapse was the adjacency of a PSD-95 and synapsin punctum of a 
minimum size of 0.2 μm × 0.2 μm × 0.07 μm which corresponds to 2 px × 2 px × 1slice. Adjacency is defined as two 
puncta occupying immediately adjacent pixels, or sharing a small proportion of the pixels.
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pixels by two slices. The synapse detection method uses this information to compute an output probability image. 
The value at each pixel is the probability it belongs to the definition of a synapse. These output images are then 
thresholded, resulting in synapse detections. The details of the synapse detection method are described in43 and 
its applications to antibody characterization are studied in44. Both report extensive validation, indicating that the 
tool is ready to address the novel biological questions in this work.
Synapse type and size definitions. For the analysis presented in this work, we used the queries listed in 
Table 2. A synapse of a particular type is defined as having the relevant markers, with all the markers being of 
the specified size. For this study, we required the markers to span one or more slices, depending on the desired 
synapse size, and have a minimum x, y size of 0.2 μm × 0.2 μm. The one exception is the definition of VGluT2 
synapses where the VGluT2 marker is required to span two or more adjacent slices. This is due to the properties of 
the VGluT2 antibody, which in addition to the expected robust label of a synapse subpopulation, also gives higher, 
randomly distributed, background signal (see Supplemental Table S2 for more information).
The sizes of the detected synapses followed the expected log-normal distribution47 (Supplemental Fig. S1). For 
the analysis, each synapse type was further subdivided in three sizes: small, medium, and large. A small synapse 
is defined as having at least one of the markers on only one slice, a medium synapse is defined as having at least 
one of the markers on two slices and the rest of the markers on two or more slices, and a large synapse is defined 
as having all of the markers on three or more slices. To calculate the synapse density of small synapses, a query 
where synaptic markers span two or more slices is subtracted from a query where synaptic markers span one or 
more slices. In the same vein, to calculate the synapse density of medium synapses, a query where synaptic mark-
ers span three or more slices is subtracted from a query where the synaptic markers span two or more slices. ‘All 
synapses’ of a type are defined as having synaptic markers that span one or more slices. An important clarification 
needs to be made about this synapse size grouping. The detection of synapse markers is based on immunoreac-
tions and is therefore subject to the limitations of antibody use. The absence of immunoreactivity does not equal 
the absence of the marker, it only indicates that the marker is below detectable levels. Therefore, a small synapse 
with synapsin label on only one slice does not equal a synapse with a presynaptic bouton confined within the 
volume of one section of 70 nm, rather, this is a synapse with detectable levels of synapsin on only one section.
Volume calculation. Synapse density is calculated as the number of synapses detected in a dataset over the 
volume of the dataset. The volume of the dataset is defined by the volume of the neuropil (i.e., excluding the volume 
occupied by cell nuclei and large blood vessels, which can vary significantly between areas). When choosing the 
areas to image, we avoided large blood vessels. To calculate the volume of cell nuclei, the nuclear stain DAPI was con-
verted into probability space using the methods outlined in44. Briefly, the value at each pixel in probability space is 
the probability it belongs to the foreground, with a range of 0 to 1. To do so, the background noise is modeled and the 
foreground probability is one minus the probability the pixel belongs to the background. The background noise is 
modeled as a Gaussian, for which the mean and variance are calculated from the raw data itself. Once the probability 
map is calculated, it is thresholded (t = 0.6, chosen by observation) and cleaned up by a sequence of morphological 
operations. The code is available for download on the project’s website. In summary, the volume of the neuropil was 
obtained by subtracting the volume of the DAPI stained nuclei from the total imaged volume.
colocalization analysis. To examine the spatial relationships between glial and postsynaptic markers, we 
used the Colocalization test in Fiji45, applying the van Steensel method of randomization48. For each pair of chan-
nels, we used a 40 × 26 μm region of interest through the image stack. The excitatory and inhibitory presynaptic/
postsynaptic marker pairs, VGluT1/PSD95 and GAD/Gephyrin were used for comparison.
Statistical analysis. Statistical analysis to determine significance between the two populations was done via 
a two-tailed unpaired t-test, shown to be applicable to very small sample sizes49, such as used in this study (n = 4). 
Because of the potential problems with any small sample statistical test, we are also presenting the data from each 
individual sample in the supplemental figures section. Plots showing the data for each synapse type, size, and layer 
are found in Supplemental Figs S2, S3, S4, S5, S6 and S7. Alternative statistical analysis could be carried out with 
the data and code we publicly provide.
Synapse Type Presynaptic Markers Postsynaptic Markers Astrocyte Marker
Glutamatergic Synapsin PSD-95 None
Glutamatergic VGluT1 Synapsin, VGluT1 PSD-95 None
Glutamatergic VGluT2 Synapsin, VGluT2 PSD-95 None
Glutamatergic VGluT1/VGluT2 Synapsin, VGluT1, VGluT2 PSD-95 None
GABAergic Synapsin, GAD Gephyrin None
Glutamatergic adjacent to astrocyte Synapsin PSD-95 GS
Glutamatergic VGluT1 adjacent to astrocyte Synapsin, VGluT1 PSD-95 GS
Glutamatergic VGluT2 adjacent to astrocyte Synapsin, VGluT2 PSD-95 GS
Glutamatergic VGluT1/VGluT2 adjacent to astrocyte Synapsin, VGluT1, VGluT2 PSD-95 GS
GABAergic adjacent to astrocyte Synapsin, GAD Gephyrin GS
Table 2. Queries used for this analysis.
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Results
We used immunofluorescent array tomography (IF-AT) to quantify the synaptic density, composition and glial 
involvement in layers 1 through 4 of the somatosensory cortex of adult FMR1 knockout (KO) mice and wild-type 
(WT) mice. IF-AT is based on digital reconstruction of images acquired from arrays of serial ultrathin sections 
(70 nm) attached to coverslips, immunofluorescently labeled and imaged under a fluorescence microscope. The 
use of ultrathin sections allows the light level detection of individual synapses, while the possibility of applying 
multiple immunofluorescent markers (10 or more) enables the identification of different synaptic populations41. 
Synaptic density was quantified using automatic synapse detection methods previously developed by our 
group43,44. Besides the already published validation of our method, results from WT mice were also compared to 
available estimates in the literature as an additional control.
overview of the datasets and detected synapses. Volumes of approximately 140 × 400 × 2.7 μm 
spanning layers 1 through 4 of the somatosensory cortex of FMR1 KO mice and WT mice were imaged, as shown 
in Fig. 3. We detected an average of 200,000 synapses in each volume for a total of approximately 1.6 million 
synapses across all eight datasets. Excitatory synapses were identified by the presence of immunofluorescent 
signals from both synapsin, a presynaptic protein, and PSD-95, a protein of the postsynaptic scaffold of excitatory 
synapses. Excitatory synapses were further subdivided depending on their vesicular glutamate transporters into 
VGluT1 positive, generally thought to be of intracortical origin, and VGluT2 positive, belonging predominantly 
to thalamocortical inputs28,29,50. Inhibitory synapses were identified by the presence of the general presynap-
tic marker synapsin and the presynaptic marker for GABAergic synapses, glutamic acid decarboxylase (GAD), 
together with the postsynaptic marker gephyrin. Astrocytes, including their processes, were detected using an 
antibody against glutamine synthetase (GS)51,52, which allowed for the identification of the fraction of synapses 
that are immediately adjacent to astrocytic processes. In addition to identifying synapses based on combinations 
of different markers, synapses were also analyzed based on their size, because size is known to correlate with the 
maturity and strength of a synaptic connection. Newly formed synapses tend to be small, and at mature synapses 
the size of the postsynaptic density is known to correlate well with synaptic strength53. Visual inspection of the 
datasets did not uncover any obvious differences in immunofluorescence intensity and pattern for any of the 
markers between the KO and WT mice. The cortical thickness was also comparable between the two conditions 
(0.88 ± 0.03 mm for KO vs. 0.89 ± 0.02 mm for WT, p = 0.71).
Single channel analysis. We first quantified the puncta density of the different synaptic markers in the KO 
and WT mice. This is a rather crude analysis, especially for the small puncta which are present on only one slice 
and therefore potentially include nonspecific label. However, these results provide an overview of the data and 
also serve to highlight the importance of the subsequent synapse detection as a much more reliable tool for mon-
itoring synaptic changes. Quantification of the puncta density of the different synaptic markers did not reveal any 
statistically significant differences (p > 0.05) when averaging Layers 1–4, as shown in Fig. 3B and in more detail 
in Supplemental Fig. S2. There was a tendency for a decrease in the number of small VGluT2 puncta (p = 0.065) 
and large PSD95 puncta (p = 0.065). On the other hand, medium PSD-95 puncta tended to increase (p = 0.056), 
as shown in the middle panel of Fig. 3.
The only significant change that was detected was in the density of GS puncta of different sizes: in FMR1 KO 
mice there were more small puncta (p = 0.01), as well as a tendency for a decrease in the number of large GS 
puncta (p = 0.07), as shown in the bottom panel of Fig. 3.
Even though we did not detect any significant changes in the densities of puncta of the different synaptic 
markers, this does not necessarily preclude changes in the synaptic populations of FMR1 KO mice. The synaptic 
proteins assessed in our study are indeed highly enriched at synapses, but they are also found at extra-synaptic 
sites, and thus their presence does not necessarily equate to the presence of a synapse.
overall synapse densities. A much more accurate detection of synapses is achieved by using combinations 
of synaptic makers, ideally at least one presynaptic and one postsynaptic marker, as specified by our synapse 
detection algorithm43,44. Indeed, using such combinations of synaptic markers, the detected synapse densities and 
distributions in WT mice are consistent with previous estimates as shown in Fig. 4. The overwhelming major-
ity of cortical synapses are known to be either excitatory glutamatergic or inhibitory GABAergic synapses54. 
Thus, the total density of synapses was estimated by the sum of the densities of the detected glutamatergic (syn-
apsin + PSD95 markers) and GABAergic synapses (synapsin + GAD + gephyrin markers) resulting in approxi-
mately 1.94 synapses per μm3 of embedded tissue. Because tissue dehydration and embedding with our protocol 
result in approximately 23% linear shrinkage, or 54% volumetric shrinkage55, this equals to 0.9 synapses per μm3 
of unprocessed tissue, very similar to the reported synapse density in mouse cortex56.
The relative contributions of inhibitory and excitatory synapse types that we detect are consistent with the 
known synapse composition of mouse cortex. The percent of inhibitory GABAergic synapses in our detections 
varies between 12% in layer 1 to 20% in layer 4 (Fig. 4F). Electron microscopy (EM) counts in mouse somatosen-
sory cortex show that inhibitory synapses consist of 11% of the synapses in layer 157 and 18% of the synapses in 
layer 458.
The layer distribution of VGluT2 synapses is consistent with their known preference for layer 4 (Fig. 4G). 
VGluT2 is known to label thalamocortical synapses which target mostly layer 4 and lower layer 2/359,60. 
Thalamocortical synapses, identified either by degeneration techniques, anterograde transport of lectin, or 
VGluT2 immunostaining, have been shown to comprise approximately 20% of glutamatergic synapses in layer 4 
of mouse somatosensory cortex61–63 and we indeed see 21% in layer 4.
To further verify the accuracy of our detections, we used a different way to calculate the density of excita-
tory glutamatergic synapses. These synapses can be subdivided into two major populations depending on the 
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Figure 3. Overview of the datasets. (A) Immunofluorescent array tomography of wild-type and FMR1 
knockout mouse somatosensory cortex. The left panel shows the imaged area in each sample, consisting of 
four tiles spanning cortical layers 1 through 4. DAPI staining of nuclei, volume reconstruction of 30 serial 
sections, 70 nm each. The right panel shows the immunofluorescence for synaptic (synapsin, VGluT1, VGluT2 
and GAD2) and glial (GS) markers in wild-type and knockout mouse somatosensory cortex layer 4, volume 
reconstruction of 10 serial sections, 70 nm each. (B) Summary of single channel punctum density changes 
between wild-type and knockout mice with all layers averaged. The plots show the percentage difference 
between the wild-type and knockout mice and are color-coded to indicate direction of change and statistical 
significance. (C) This plot shows the density distribution of GS puncta by size. ‘Small’ puncta span one slice, 
‘medium’ puncta span two slices, and ‘large’ puncta span three or more slices.
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vesicular glutamate transporters (VGluTs) at the presynaptic site, with the majority of excitatory synapses con-
taining VGluT1, and a smaller population, mostly concentrated in layer 4, VGluT2. In addition, some synapses 
express both VGluT1 and VGluT264. Thus, the density of glutamatergic synapses should be approximately equal 
to the densities of VGluT1 and VGluT2 synapses minus VGluT1/VGluT2 synapses to prevent double counting of 
the same synapse. This was indeed the case, as seen in Table 3.
Changes in synaptic densities in FMR1 KO mice. Next, we compared the densities of the different 
synapse populations in the WT mice to the FMR1 KO mice. Even though the individual synaptic marker puncta 
did not show any statistically significant differences in the two conditions, there were wide-ranging changes in 
synaptic densities. These changes were dependent on the synapse type, size, as well as cortical layer, as shown in 
Fig. 5 and in more detail in Supplemental Fig. S3. There was an increase of small glutamatergic VGluT1 synapses 
in layer 4 accompanied by a decrease in large VGluT1 synapses in layers 1 and 4. VGluT2-containing synapses, 
on the other hand, showed a rather consistent decrease in density in layers 1 and 2/3. Large inhibitory synapses 
decreased across all layers examined without detected changes in small and medium size inhibitory synapses.
These changes in density of the various synaptic populations resulted in an increase in the excitation-inhibition 
ratio in the FMR1 KO mice, consistent with previous reports: 6.20 ± 0.56 for the KO vs. 5.24 ± 0.32 in WT (average 
Figure 4. Overview of wild-type synapse density distributions. (A) Top, multiplexed immunofluorescence 
from the same area of a single section of the somatosensory cortex of a WT mouse. The nuclear stain DAPI is 
in cyan. White squares highlight individual synapses, which in A, bottom, are shown at higher magnification 
on 4 consecutive serial sections. (B) The distribution of synapse types across different layers. Layers with 
significant differences for a synapse type are marked. While there is no significant difference in layer densities 
for glutamatergic synapses overall and for glutamatergic synapses with VGluT1, there is a significant difference 
between layers for glutamatergic synapses with VGluT2, with both VGluT1 and VGluT2, and for inhibitory 
synapses. (C) Fraction of inhibitory synapses in layers 1 through 4 of mouse somatosensory cortex. (D) Fraction 
of VGluT2 synapses in layers 1 through 4 of the mouse somatosensory cortex.
Glut VGluT1 + VGluT2-VGluT1/2
L1 1.617 1.629
L2/3 1.700 1.750
L4 1.574 1.585
Table 3. Density distribution of excitatory synapses across layers as calculated by two methods. Units are 
number of synapses per cubic micron.
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for layers 1 through 4; p = 0.04). Similar increase was observed in all examined layers, but it did not reach statistical 
significance. Excitation was defined by the number of synapses which contain synapsin and PSD95, and inhibition 
by the number of synapses containing synapsin, GAD and gephyrin. These changes are highlighted in Fig. 6G.
Because the strength of excitatory synapses is known to be proportional to the size of the postsynaptic density, we 
also analyzed the changes specifically at the postsynaptic side as shown in Fig. 6A–F and in more detail in Supplemental 
Fig. S4. There was a statistically significant increase in the density of glutamatergic and specifically VGluT1 synapses 
with small PSD-95 puncta (spanning only 1 or 2 slices), and a significant decrease in the density of the VGluT2 synapses 
with large PSD-95 puncta (spanning 6 or more slices). No changes in the densities of inhibitory synapses depending on 
the size of gephyrin puncta were detected, as shown in more detail in Supplemental Fig. S5.
Figure 5. Changes in synapse densities across layers. (A) Summary table showing the synapse types that have 
a significant increase or decrease in synapse density between wild-type and knockout mice. Each row shows 
plots of the percentage difference in density between the wild-type and knockout mice. Plots are color-coded 
to indicate direction of change and statistical significance. (B–D) Differences in synapse density for different 
synapse types for three expected synapse sizes.
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involvement of glia (astrocytes). Astrocytes are intimately involved in synaptic function and their pro-
cesses are found adjacent to many synaptic clefts in the neocortex. Because astrocytes in the mouse also express 
FMRP34 and are suspected to have a role in FXS pathogenesis36, we analyzed the potential changes in astro-
cytic involvement at synapses in the FMR1 KO mice. Astrocytes were detected using antibodies to glutamine 
Figure 6. Postsynaptic marker size distributions. (A) Summary table showing the differences in the size 
distributions of PSD-95 puncta associated with synapses by type. The main takeaway is that for excitatory 
synapses overall, there is an increase in the number of small PSD-95 puncta in FMR1 knockout mice while there 
is a decrease in the number of very large PSD-95 puncta associated with synapses containing VGluT2. (B–E) 
Plots showing the distribution of PSD-95 puncta for both wild-type and knockout mice. (F) Size distribution 
of gephyrin puncta associated with inhibitory synapses. (G) Plot shows the significant increase in the ratio of 
excitatory to inhibitory synapses in knockout mice.
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synthetase, an enzyme known to be expressed predominantly by this cell type51,52 and specifically found at the 
peripheral astrocytic processes that contact synapses65,66. Figure 7A shows an example of the data.
In wild-type mice, we found that the majority of glutamatergic synapses (72 ± 2%) are adjacent to astrocytic 
processes as detected by immunolabel to glutamine synthetase. This is very similar to previous EM estimates in 
mouse somatosensory cortex layer 4, where 68% of glutamatergic synapses on dendritic spines were in contact 
with astrocytic processes at the bouton-spine interface67. The proportion of glutamatergic synapses in contact 
with astrocytes was not uniform across layers, and we detected the highest association in layer 2/3 (Fig. 7D), 
similarly to previous observations in rat visual cortex68. Interestingly, we observed significant differences in the 
astrocytic association of the different synapse types, as shown in Fig. 7B. Thus, compared to the majority glu-
tamatergic synapses containing VGluT1 (61 ± 2% astrocytic association), significantly less VGluT2 synapses 
(46 ± 1%, p < 0.001) were adjacent to astrocytes. The difference in astrocytic association was even more pro-
nounced when considering the inhibitory GAD synapses which were half as likely to be adjacent to an astrocytic 
process (29 ± 1%, p < 0.001) compared to excitatory VGluT1 synapses.
Figure 7. Astrocytic association of synapses in wild-type mice. (A) Portion of the wild-type synapse data with 
a synapse highlighted with a white box. Below are serial sections through the highlighted synapse, shown at 
higher magnification. (B) The fraction of synapses associated with astrocytes varies depending on synapse 
type. (C) Cross-correlation score as a function of lateral offset between the two channels. The synaptic marker 
pairs VGluT1 - PSD-95 and GAD - Gephyrin are shown for comparison. The correlation between the synaptic 
markers is high with no shift and it drops off sharply with lateral offset, as expected for tightly correlated 
presynaptic and postsynaptic markers. On the other hand, GAD and VGluT1 do not colocalize, because they 
label different synapse types, and the negative colocalization score with no shift gradually increases to 0 with 
lateral offset. (D) Between layer differences in the astrocytic association of different synapse types.
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Because there are no previous data about differences in glial association of cortical excitatory and inhibitory 
synapses, we sought additional evidence to confirm this finding. We quantified the colocalization between the 
astrocytic marker (GS) and the postsynaptic markers for excitatory (PSD95) and inhibitory (gephyrin) synapses 
using the van Steensel method48. This method evaluates the extent of spatial correlation by testing for the effect 
of very small relative displacements between pairs of marker images on a measurement of image overlap, the 
Pearson correlation coefficient. Because of the abundance of synaptic and glial markers, overlapping spatial dis-
tributions might occur by chance. If the association between two channels is real, however, then any shift of one 
channel relative to the other will decrease the observed degree of colocalization. On the other hand, if two chan-
nels tend to be mutually exclusive, then a shift will increase the degree of colocalization. Finally, if the association 
between two channels is occurring by chance, then a shift will not substantially affect the degree of colocalization. 
Because this analysis was performed on volumes containing several thousand synapses, which in cortex have 
random orientations, the change in the degree of colocalization between two channels does not depend on the 
direction of the shift, but only on its size. Consistent with our findings with the probabilistic synapse detector, the 
van Steensel method detected a colocalization between the astrocytic marker GS and the postsynaptic excitatory 
marker PSD95 (Fig. 7C). The degree of colocalization increased with shifts between the two channels of up to 
0.3–0.4 μm, suggesting that the two markers are adjacent, but not overlapping. No colocalization was detected 
between GS and the postsynaptic inhibitory marker gephyrin. This does not mean that GS was not present next 
to a portion of inhibitory synapses, it only signifies that GS was not preferentially associated with inhibitory 
synapses. This result is consistent with our finding that excitatory synapses are more likely to be associated with 
astrocytic processes compared to inhibitory synapses.
Comparison of WT with KO mice revealed a number of significant changes in astrocytic involvement at 
synapses. Consistent with the detected overall changes in synaptic density, there were significant decreases in the 
densities of synapses adjacent to astrocytes, for almost all synapse types and sizes as shown in Fig. 8A and in more 
detail in Supplemental Fig. S6. The only exception were the small glutamatergic synapses in layer 4, for which the 
density of synapses adjacent to astrocytes increased in KO mice. While the density of synapses adjacent to astro-
cytes is very much influenced by the changes in overall synaptic density, the fraction of synapses adjacent to astro-
cytes reflects the actual changes in glial involvement in Fragile X Syndrome. There was an overall decrease in the 
fraction of synapses adjacent to astrocytes for all synapse types and layers, but the differences did not reach sta-
tistical significance in many cases, likely due to the large variability within each genotype. A significant decrease 
in the fraction of synapses adjacent to astrocytes was detected for glutamatergic and VGluT1 synapses of all sizes, 
except small VGluT1 synapses (layers 1–4 combined) as shown in Fig. 8B and in more detail in Supplemental 
Fig. S7. When analyzed by cortical layer, there were significant decreases in the fraction of astrocytic association 
for large glutamatergic synapses in layers 1 and 2/3, large VGluT1 synapses in layer 1, small and medium VGluT2 
synapses in layers 2/3, and medium GAD synapses in layer 1.
Discussion
Using immunofluorescent array tomography and automatic probabilistic synapse detection methods we show 
wide-ranging changes of synapses and their association with astrocytes in the somatosensory cortex of adult 
FMR1 knock-out mice, a Fragile X mouse model. Overall, there is a significant decrease in the density of excita-
tory glutamatergic synapses and their association with astrocytes. However, the changes vary greatly, and are at 
times in opposite directions, depending on synapse type, size, as well as cortical layer. The changes in supragranu-
lar layers (layers 1 and 2/3) reflect the overall decrease in the density of glutamatergic synapses, predominantly of 
the VGluT2 type. Meanwhile in the granular layer (layer 4) there is a slight but significant increase in the density 
of glutamatergic synapses, resulting from an increase in small VGluT1 synapses, offset by a decrease in large 
VGluT1 synapses. The astrocytic association of excitatory synapses decreases. As for the inhibitory GABAergic 
synapses, there is a consistent decrease in the density of large synapses in all examined layers, and a decrease in 
the astrocytic association of medium-sized synapses in layer 1. The overall loss of inhibitory synapses is greater 
than for excitatory synapses, suggesting a potential shift in the excitation/inhibition ratio toward greater excita-
tion in FMR1 knock-out mice. Thus, the absence of FMRP markedly alters the neocortical synaptic circuitry by 
both changing the relative contributions of synapses of different types, and the astrocytic involvement at synapses.
Our results are consistent with reported data in adult FMR1 knock-out mice suggesting cortical circuit 
changes such as increase in smaller size immature synapses and decrease in larger size synapses (as evidenced 
by the spine size in35,69), as well as decreased association of astrocytes with hippocampal synapses35. We have 
extended these observations, by showing that these changes are not uniform, but depend on the synapse type, as 
well as cortical layer. A previous study had indeed shown that layers 4 and 5 synapses of different types in mouse 
somatosensory cortex exhibit various deficits in FMR1 knock-out mice31 and we have now characterized the syn-
apse type specific changes in the supragranular layers as well. Finally, we are showing for the first time a decrease 
in astrocytic involvement at neocortical excitatory glutamatergic synapses, most pronounced at medium and 
large size synapses.
A potential caveat of our study is the small number of analyzed animals, due to the laborious nature of these 
experiments. In order to minimize variations between experimental sessions and obtain more accurate results, 
our original design was to immunolabel and image the samples in pairs, one KO and one WT. The subsequent 
analysis revealed good consistency from experiment to experiment, as evidenced by the individual data points 
presented in the Supplemental figures, which enabled the detection of multiple synaptic changes in the FMR1 
KO mice regardless of the small number of animals. In addition, comparison of our results from WT mice to 
the available published data, further confirmed that we are not only able to correctly quantify the densities of the 
two main synapse types, excitatory and inhibitory, but that we are also detecting the known layer variations in 
VGluT2 synapses61–63, and even the rather subtle layer variations in astrocytic association of excitatory synapses68. 
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Nevertheless, the rather large variability within genotype for some of the synapse types and cortical layers likely 
prevented us from detecting all changes at the synapses of the FMR1 KO mice. Thus, the fact that we did not 
observe statistically significant changes in the astrocytic involvement at synapses in layer 4, should not be inter-
preted as evidence for a lack of change. Further experiments involving larger numbers of animals are needed to 
conclusively address this issue.
Our findings raise important questions about the implications of the observed changes in the neocortical syn-
aptic circuitry of FMR1 KO mice. These changes are complex, involving a variety of synapse types, as well as glia. 
There is a shift in the size of excitatory, presumably intracortical VGluT1 synapses, manifested in the increase in 
small VGluT1 synapses and a decrease of large VGluT1 synapses. As synapse size is known to correlate with the 
strength of the synapse, this change implies a decrease in stronger VGluT1 synapses. There is also a decrease in 
the density of VGluT2, presumably thalamocortical synapses, also known to be strong synapses70. Concomitantly, 
there is a decrease in the astrocytic involvement at glutamatergic synapses, likely resulting in impaired glutamate 
uptake71. The combination of these changes suggests a decrease in glutamatergic signaling in the somatosensory 
cortex of FMR1 KO mice, arising from fewer strong intracortical and thalamocortical synapses. This might be 
accompanied by a loss of the acuity of those connections, since fewer closely associated astrocytes might result in 
more glutamate spill over at these synapses. The concomitant loss of inhibitory synapses might counteract the loss 
of excitatory signal strength to some extent, but might also contribute to the loss of acuity, essentially decreasing 
the functional signal-to-noise ratio of the circuit in FMR1 KO mice. It is known that somatosensory processing 
is abnormal in FMR1 KO mice12,13, and a decreased signal-to-noise ratio could be contributing to many of the 
deficits, for example, to the blurred whisker maps observed in FMR1 KO mice72,73. Interestingly, the decrease in 
sensory tuning is observed in layers 2/3, but not layer 4 of FMR1 KO mouse somatosensory cortex72, consistent 
with the much larger changes in the layer 2/3 synaptic circuitry that we report.
A common hypothesis regarding the functional deficits in autism focuses on the imbalance in the excita-
tion and inhibition74. While our results are consistent with an increase in the excitation/inhibition ratio, they 
also highlight the complexity of changes that might contribute to this effect, and support the notion that the 
excitation/inhibition ratio is a measure that lumps together a variety of changes in the synaptic circuitry that 
likely have diverse functional consequences75. Furthermore, we also show that, in addition to synapses, there 
are specific deficits in cortical astrocytes and their interactions with synapses. The most pronounced changes 
Figure 8. Summary of the astrocytic synapse density differences in the knockout mice. (A) Changes are 
shown as the percentage difference in density between the wild-type and knockout mice. Plots are color-coded 
to indicate direction of change and statistical significance. The density decreases between the wild-type and 
knock-out mice for Layers 1–3 and the difference is especially pronounced for medium and large synapses. (B) 
Changes in the fraction of synapses adjacent to astrocytic processes.
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occur at glutamatergic synapses. Indeed, it has been shown that glutamatergic but not GABAergic neurons, crit-
ically depend on the presence of glia to establish synaptic transmission76. Studies employing selective deletion of 
FMRP in astrocytes strongly suggest the involvement of these glial cells in Fragile X pathogenesis36, likely through 
impaired glutamate uptake71. Interestingly, the decrease in astrocytic association of glutamatergic synapses may 
have a different effect on VGluT1 and VGluT2 synapses and may thus contribute to the heterogeneous changes 
in these 2 synapse types. Thus, in developing visual cortex astrocytes have been shown to secrete hevin, a protein 
that stabilizes specifically VGluT2 synapses77. The decrease in astrocytic presence at glutamatergic synapses, and 
therefore decreased hevin concentration, may result in loss of some VGluT2 synapses without affecting VGluT1 
synapses. It thus appears that in Fragile X Syndrome astrocytes may mediate at least some of the pathological 
effects on glutamatergic synapses78–80.
Overall, our study reveals complex, synapse-type and layer specific changes in the somatosensory cortex of 
FMR1 knock-out mice. Some of these changes are in opposite directions, or affect only a small population of 
synapses and therefore become obscured when analyzing the overall synaptic content. The ability to dissect the 
deficits by specific synapse categories, as well as astrocytic involvement, are crucial for understanding the overall 
picture of synaptic changes, to begin to unravel the multiple ways in which they affect circuit function, and ulti-
mately define targets for therapeutic treatment and prevention.
Data and code Availability
The code and raw data are available for download at https://aksimhal.github.io/astrocytes-synapses-fxs/.
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